Mantle cell lymphoma
Concept
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
2013 · Michael Wang, Simon Rule, et al. · New England Journal of Medicine
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
2020 · Michael Wang, Javier Muñoz, et al. · New England Journal of Medicine
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 · Mathias Rummel, N. Niederle, et al. · The Lancet